Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Guardant Health, Inc. | Chief Commercial Officer | Restricted Stock Units | 30.2K | $712K | $23.60 | Nov 8, 2024 | Direct |
Guardant Health, Inc. | Chief Commercial Officer | Common Stock | 31.5K | $696K | $22.12 | Oct 1, 2024 | Direct |
Guardant Health, Inc. | Chief Commercial Officer | Stock Option (Right to Buy) | 45.2K | Nov 8, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
GH | Guardant Health, Inc. | Nov 8, 2024 | 2 | $0 | 4 | Nov 12, 2024 | Chief Commercial Officer |
GH | Guardant Health, Inc. | Oct 1, 2024 | 5 | -$80.1K | 4 | Oct 2, 2024 | Chief Commercial Officer |
GH | Guardant Health, Inc. | Sep 15, 2024 | 3 | -$16K | 4 | Sep 16, 2024 | Chief Commercial Officer |
GH | Guardant Health, Inc. | Jul 1, 2024 | 3 | -$21.4K | 4 | Jul 2, 2024 | Chief Commercial Officer |
GH | Guardant Health, Inc. | Jun 15, 2024 | 5 | -$86.7K | 4 | Jun 17, 2024 | Chief Commercial Officer |
GH | Guardant Health, Inc. | Apr 1, 2024 | 3 | -$10.8K | 4 | Apr 2, 2024 | Chief Commercial Officer |
GH | Guardant Health, Inc. | Jan 1, 2024 | 3 | -$17.1K | 4 | Jan 3, 2024 | Chief Commercial Officer |
GH | Guardant Health, Inc. | Dec 13, 2023 | 2 | $0 | 4 | Dec 15, 2023 | Chief Commercial Officer |
GH | Guardant Health, Inc. | Oct 1, 2023 | 3 | -$63.1K | 4 | Oct 2, 2023 | Chief Commercial Officer |
GH | Guardant Health, Inc. | Jun 15, 2023 | 3 | -$51K | 4 | Jun 16, 2023 | Chief Commercial Officer |
GH | Guardant Health, Inc. | Jun 9, 2023 | 2 | $0 | 4 | Jun 13, 2023 | Chief Commercial Officer |
GH | Guardant Health, Inc. | Nov 7, 2022 | 2 | $0 | 4 | Nov 9, 2022 | Chief Commercial Officer |
GH | Guardant Health, Inc. | Jun 15, 2022 | 3 | -$64.9K | 4 | Jun 17, 2022 | Chief Commercial Officer |
GH | Guardant Health, Inc. | Aug 3, 2021 | 2 | $0 | 4 | Aug 5, 2021 | Chief Commercial Officer |
GH | Guardant Health, Inc. | Jun 28, 2021 | 0 | $0 | 3 | Jul 8, 2021 | Chief Commercial Officer |